Back to results
US 2025/0051836 A1Published application
Method for amplifying rna in a sample
AssigneeQiagen GmbH
InventorColin DONOHOE
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for amplifying a target RNA in a sample, an oligonucleotide usable in the method according to the invention, a kit for amplifying a target RNA, and a use of an oligonucleotide for inhibiting an aptamer oligonucleotide.
Claims26
1-15. (canceled)
A method for amplifying a target RNA in a sample comprising the following steps:
- (i) providing a reaction mixture at a first temperature, said reaction mixture comprising:
- the sample;
- a reverse transcriptase enzyme;
- a DNA polymerase enzyme;
- a mixture of deoxyribonucleoside triphosphates (dNTPs);
- at least one primer configured to convert the target RNA into complementary DNA (cDNA) and/or to amplify said cDNA;
- an aptamer oligonucleotide configured to specifically inhibit the reverse transcriptase enzyme, and
- an inhibitor of the aptamer oligonucleotide,
- (ii) reverse transcribing said target RNA into cDNA by incubating said reaction mixture at a second temperature higher than said first temperature resulting in an at least partial unfolding of said aptamer oligonucleotide and an inhibition of the latter by said inhibitor, and
- (iii) amplifying said cDNA by polymerase chain reaction.
7 more elements
An oligonucleotide comprising the following nucleotide sequence:
- (SEQ ID NO:
- 2)
- 5′-AGTTTTGGCCATGGCGCTAGCAGTTAAGAGCGCGTGGTAAG-3′.
A kit for amplifying a target RNA, comprising:
- a reverse transcriptase enzyme;
- a DNA polymerase enzyme;
- a mixture of deoxyribonucleoside triphosphates (dNTPs);
- at least one primer configured to convert the target RNA into complementary DNA (cDNA) and/or to amplify said cDNA;
- an aptamer oligonucleotide configured to specifically inhibit the reverse transcriptase enzyme, and
- an inhibitor of the aptamer oligonucleotide.
3 more elements
Dependencies are inferred from the claim text.